Hallervorden-Spatz Syndrome
|
0.800 |
CausalMutation
|
disease |
CLINVAR |
A Novel Nonsense Mutation in PANK2 Gene in Two Patients with Pantothenate Kinase-Associated Neurodegeneration.
|
28357202 |
2016 |
Hallervorden-Spatz Syndrome
|
0.800 |
Biomarker
|
disease |
BEFREE |
We exploited the zebrafish model to study the role played by the pank2 gene during embryonic development and get new insight into PKAN pathogenesis.
|
26476142 |
2016 |
Hallervorden-Spatz Syndrome
|
0.800 |
GeneticVariation
|
disease |
UNIPROT |
A novel gene mutation in PANK2 in a patient with severe jaw-opening dystonia.
|
27185474 |
2016 |
Hallervorden-Spatz Syndrome
|
0.800 |
CausalMutation
|
disease |
CLINVAR |
Diagnostic exome sequencing provides a molecular diagnosis for a significant proportion of patients with epilepsy.
|
26795593 |
2016 |
Hallervorden-Spatz Syndrome
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Pantothenate kinase-associated neurodegeneration (PKAN) is an autosomal recessive disorder characterized by iron accumulation in the brain, because of mutations in the PANK2 gene.
|
24712887 |
2015 |
Hallervorden-Spatz Syndrome
|
0.800 |
CausalMutation
|
disease |
CLINVAR |
Acanthocytosis and the c.680 A>G Mutation in the PANK2 Gene: A Study Enrolling a Cohort of PKAN Patients from the Dominican Republic.
|
25915509 |
2015 |
Hallervorden-Spatz Syndrome
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Pantothenate kinase associated neurodegeneration is a hereditary disease that arises from mutations that inactivate the human PANK2 gene.
|
26549575 |
2015 |
Hallervorden-Spatz Syndrome
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Herein we report the first case in which deep brain stimulation helped to relieve dystonic storm in a patient with PKAN syndrome who had homozygous c.628 2 T > G mutation of the PANK2 gene.
|
26223911 |
2015 |
Hallervorden-Spatz Syndrome
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Classic form of pantothenate-kinase-associated neurodegeneration (PKAN), caused by mutation in PANK2 gene, is characterized by early onset, severe neurological impairment and rapid disease progression.
|
25724846 |
2015 |
Hallervorden-Spatz Syndrome
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Pantothenate kinase-associated neurodegeneration (PKAN) is a progressive movement disorder that is due to mutations in PANK2.
|
26547561 |
2015 |
Hallervorden-Spatz Syndrome
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
It has not been investigated yet whether acanthocytosis in PKAN is associated with a specific subset of Pank2 mutations.
|
25915509 |
2015 |
Hallervorden-Spatz Syndrome
|
0.800 |
GeneticVariation
|
disease |
UNIPROT |
Novel homozygous PANK2 mutation causing atypical pantothenate kinase-associated neurodegeneration (PKAN) in a Cypriot family.
|
24655737 |
2014 |
Hallervorden-Spatz Syndrome
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Novel homozygous PANK2 mutation causing atypical pantothenate kinase-associated neurodegeneration (PKAN) in a Cypriot family.
|
24655737 |
2014 |
Hallervorden-Spatz Syndrome
|
0.800 |
Biomarker
|
disease |
BEFREE |
It has been postulated that pantothenate kinase-associated neurodegeneration (PKAN) is not synucleinopathy.
|
24981186 |
2014 |
Hallervorden-Spatz Syndrome
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
The patient was found to have two mutations in the pantothenate kinase 2 (PANK2) gene that have been previously associated with pantothenate kinase-associated neurodegeneration: a paternally inherited p.G521R and maternally inherited p.T528M.
|
23968566 |
2013 |
Hallervorden-Spatz Syndrome
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Novel PANK2 gene mutations in two Chinese siblings with atypical pantothenate kinase-associated neurodegeneration.
|
22930366 |
2013 |
Hallervorden-Spatz Syndrome
|
0.800 |
CausalMutation
|
disease |
CLINVAR |
Due to limited phenotype-genotype correlation among patients with movement disorders, if "eye-of-the-tiger" brain MRI is present, PANK2 mutations investigation are needed to confirm PKAN disease.
|
24075960 |
2013 |
Hallervorden-Spatz Syndrome
|
0.800 |
GeneticVariation
|
disease |
UNIPROT |
Novel PANK2 gene mutations in two Chinese siblings with atypical pantothenate kinase-associated neurodegeneration.
|
22930366 |
2013 |
Hallervorden-Spatz Syndrome
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Due to limited phenotype-genotype correlation among patients with movement disorders, if "eye-of-the-tiger" brain MRI is present, PANK2 mutations investigation are needed to confirm PKAN disease.
|
24075960 |
2013 |
Hallervorden-Spatz Syndrome
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Pantothenate kinase-associated neurodegeneration (PKAN, NBIA1) and PLA2G6-associated neurodegeneration (PLAN, NBIA2) are the core syndromes, but several other genetic causes have been identified (including FA2H, C19orf12, ATP13A2, CP and FTL).
|
23212724 |
2013 |
Hallervorden-Spatz Syndrome
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
PKAN and PLAN are autosomal recessive NBIA disorders due to mutations in PANK2 and PLA2G6, respectively.
|
24209433 |
2013 |
Hallervorden-Spatz Syndrome
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Mutations in the pantothenate kinase 2 gene (PANK2) are responsible for the most common type of neurodegeneration with brain iron accumulation (NBIA), known as pantothenate kinase-associated neurodegeneration (PKAN).
|
22416811 |
2013 |
Hallervorden-Spatz Syndrome
|
0.800 |
GeneticVariation
|
disease |
UNIPROT |
Due to limited phenotype-genotype correlation among patients with movement disorders, if "eye-of-the-tiger" brain MRI is present, PANK2 mutations investigation are needed to confirm PKAN disease.
|
24075960 |
2013 |
Hallervorden-Spatz Syndrome
|
0.800 |
CausalMutation
|
disease |
CLINVAR |
"Missense PANK2 mutation without ""eye of the tiger"" sign: MR findings in a large group of patients with pantothenate kinase-associated neurodegeneration (PKAN)."
|
22127788 |
2012 |
Hallervorden-Spatz Syndrome
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Missense PANK2 mutation without "eye of the tiger" sign: MR findings in a large group of patients with pantothenate kinase-associated neurodegeneration (PKAN).
|
22127788 |
2012 |